@article{oai:niigata-u.repo.nii.ac.jp:00022186,
 author = {品田, 章二 and 小島, 秀男 and 佐藤, 善計 and 渡辺, 苗美 and 石黒, 真里子 and 小林, 幸子 and 土屋, ヒデ子 and 山田, 恵子 and 石口, 重子 and 富樫, 和枝 and 大竹, 幸子 and 柴田, 昭},
 issue = {7},
 journal = {新潟医学会雑誌, 新潟医学会雑誌},
 month = {Jul},
 note = {Blood components transfused to patients with hematological malignancies from 1978 to 1988 fiscal years at Niigata University Hospital were analysed and discussed. Between 52 and 98 cases were transfused each year. Since survival of hematological malignancies has been prolonged and the same case was counted as one in each fiscal year due to long survival, the patient number has gradually increased from 3.5% to 7.1% of total transfused patients. Approximately 95% of platelet concentrates （PC） supplied from Niigata Prefecture Red Cross Blood Center were transfused to these hematological malignacies. Since the introduction, in 1980, of an automatic blood component separator, patterns of blood components for leukemia and lymphoma therapy have changed markedly. In 1987 and 1988, the unit of PC processed through the separator was greater than that which was processed through sequential centrifugations of blood bags. Hospital processed granulocyte components reached peak levels in 1984, but have since decreased due to restrictions placed on these components which permit them to be used for therapeutic purpose only. In the future, we should implement a system to test HLA during their remission phase or to cryopreserve patient's own platelets in order to manage at their platelet refractoriness.},
 pages = {617--620},
 title = {新潟大学病院における造血器腫瘍疾患への輸血療法の過去11年間の変遷（第20回新潟造血器腫瘍研究会十周年記念シンポジウム : 造血器腫瘍十年の歩み）},
 volume = {104},
 year = {1990}
}